MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0096009
Urafya Pharmaceuticals Private Limited
Urafya Pharmaceuticals Private Limited - food and beverages in Lucknow, Uttar Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2024
₹77.73 Lakh
▲ 192% YoY
Net profit · FY 2024
₹4.85 Lakh
Net margin 6.2%
EBITDA · FY 2024
₹6.52 Lakh
EBITDA margin 8.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Urafya Pharmaceuticals Private Limited
Data last updated:
Urafya Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24302UP2018PTC108094. Its GSTIN is 09AACCU3185B1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Adhir Kumar Mishra and Komal Shukla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Halwasiya Court Hazratganj, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹77.73 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.85 Lakh (net margin 6.2%) and EBITDA of ₹6.52 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 100% over five years.
Urafya Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0096009).
Company details
CIN U24302UP2018PTC108094
Registration Number 108094
Incorporation Date 20 September 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0096009
Key People
Adhir Kumar Mishra Director Komal Shukla Director Recognitions & Rankings of Urafya Pharmaceuticals
Contact details
Urafya Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Social Media
- Registered Address4th Floor Halwasiya Court Hazratganj, Lucknow, Uttar Pradesh, India – 226001
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
Comprehensive company report
Urafya Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Urafya Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Urafya Pharmaceuticals Private Limited, buy the company report.
Financials of Urafya Pharmaceuticals Private Limited
FY 2025 filings availableUrafya Pharmaceuticals Private Limited reported revenue of ₹77.73 Lakh (up 192% YoY) for FY 2024.
Revenue · FY 2024
₹77.73 Lakh ▲ 192%
Net profit · FY 2024
₹4.85 Lakh margin 6.2%
EBITDA · FY 2024
₹6.52 Lakh margin 8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 45%
5 years · compounded
▲ 100%
EBITDA CAGR growth
1 year
▲ 191%
3 years · compounded
▲ 45%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 100% over five years, including 192% growth in the latest year. EBITDA rose 191% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Urafya Pharmaceuticals Private Limited, buy the company report.
Board of directors of Urafya Pharmaceuticals Private Limited
Urafya Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adhir Kumar Mishra | Director | 25 Mar 2023 | 3 Years 7 Months | Current |
| Komal Shukla | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Urafya Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Urafya Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Urafya Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCU3185B1ZG | Uttar Pradesh | Active | 26 Nov 2018 |
To see the full GST registrations and return filing status of Urafya Pharmaceuticals Private Limited, buy the company report.
Recent activity
Urafya Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Adhir Kumar Mishra was appointed as Director on 25 Mar 2023.
AGM
Urafya Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Urafya Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Appointed
Adhir Kumar Mishra was appointed as Director.
Ceased
Nishit Kumar Pathak ceased to be Director.
Appointed
Komal Shukla was appointed as Director.
Incorporation
20 Sep 2018
Urafya Pharmaceuticals Private Limited was registered on 20 Sep 2018 with Roc Uttar Pradesh I & aged 8 years 1 month as per MCA records.
Frequently asked questions
Urafya Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U24302UP2018PTC108094.
Urafya Pharmaceuticals has 2 current directors:
- Adhir Kumar Mishra - Director
- Komal Shukla - Director
The latest financial statements of Urafya Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Urafya Pharmaceuticals is 09AACCU3185B1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Urafya Pharmaceuticals is U24302UP2018PTC108094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Urafya Pharmaceuticals was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Adhir Kumar Mishra was appointed as Director on 25 Mar 2023. Nishit Kumar Pathak ceased to be Director on 25 Mar 2023. Komal Shukla was appointed as Director on 20 Sep 2018.
Yes, Urafya Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0096009).
The registered office of Urafya Pharmaceuticals is at 4th Floor Halwasiya Court Hazratganj, Lucknow, Uttar Pradesh, India – 226001.
Urafya Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages